TopBP1 contributes to the chemoresistance in non-small cell lung cancer through upregulation of p53

References

• SiegelRMaJZouZJemalACancer statistics, 2014CA Cancer J Clin201464192924399786
   PubMed Web of Science ®Google Scholar
• WangYYLinSXYangGQLiuHCSunDNWangYSClinical efficacy of CyberKnife combined with chemotherapy and hyperthermia for advanced non-small cell lung cancerMol Clin Oncol20131352753024649205
   PubMedGoogle Scholar
• ImaiHShukuyaTYoshinoREfficacy and safety of platinum combination chemotherapy re-challenge for relapsed patients with non-small-cell lung cancer after postoperative adjuvant chemotherapy of cisplatin plus vinorelbineChemotherapy201359430731324480845
   PubMed Web of Science ®Google Scholar
• PerolMChouaidCPerolDRandomized, phase III study of gemcitabine or erlotinib maintenance therapy versus observation, with predefined second-line treatment, after cisplatin-gemcitabine induction chemotherapy in advanced non-small-cell lung cancerJ Clin Oncol201230283516352422949150
   PubMed Web of Science ®Google Scholar
• OhashiRTakahashiFCuiRInteraction between CD44 and hyaluronate induces chemoresistance in non-small cell lung cancer cellCancer Lett2007252222523417276588
   PubMed Web of Science ®Google Scholar
• YangHWangWZhangYThe role of NF-E2-related factor 2 in predicting chemoresistance and prognosis in advanced non-small-cell lung cancerClin Lung Cancer201112316617121663859
   PubMed Web of Science ®Google Scholar
• PallisAGSyrigosKNEpidermal growth factor receptor tyrosine kinase inhibitors in the treatment of NSCLCLung Cancer201380212013023384674
   PubMed Web of Science ®Google Scholar
• WrightRHDornanESDonaldsonMMMorganIMTopBP1 contains a transcriptional activation domain suppressed by two adjacent BRCT domainsBiochem J2006400357358216984230
   PubMedGoogle Scholar
• YamaneKKawabataMTsuruoTA DNA-topoisomerase-II-binding protein with eight repeating regions similar to DNA-repair enzymes and to a cell-cycle regulatorEur J Biochem199725037947999461304
   PubMedGoogle Scholar
• RappasMOliverAWPearlLHStructure and function of the Rad9-binding region of the DNA-damage checkpoint adaptor TopBP1Nucleic Acids Res201139131332420724438
   PubMed Web of Science ®Google Scholar
• GarciaVFuruyaKCarrAMIdentification and functional analysis of TopBP1 and its homologsDNA Repair (Amst)20054111227123915897014
   PubMed Web of Science ®Google Scholar
• KimJEMcAvoySASmithDIChenJHuman TopBP1 ensures genome integrity during normal S phaseMol Cell Biol20052524109071091516314514
   PubMed Web of Science ®Google Scholar
• YamaneKTsuruoTConserved BRCT regions of TopBP1 and of the tumor suppressor BRCA1 bind strand breaks and termini of DNAOncogene199918375194520310498869
   PubMed Web of Science ®Google Scholar
• LiuKBellamNLinHYRegulation of p53 by TopBP1: a potential mechanism for p53 inactivation in cancerMol Cell Biol200929102673269319289498
   PubMed Web of Science ®Google Scholar
• LiuKLuoYLinFTLinWCTopBP1 recruits Brg1/Brm to repress E2F1-induced apoptosis, a novel pRb-independent and E2F1-specific control for cell survivalGenes Dev200418667368615075294
   PubMed Web of Science ®Google Scholar
• LiuKLinFTRuppertJMLinWCRegulation of E2F1 by BRCT domain-containing protein TopBP1Mol Cell Biol20032393287330412697828
   PubMed Web of Science ®Google Scholar
• HeroldSWanzelMBeugerVNegative regulation of the mammalian UV response by Myc through association with Miz-1Mol Cell200210350952112408820
   PubMed Web of Science ®Google Scholar
• CescuttiRNegriniSKohzakiMHalazonetisTDTopBP1 functions with 53BP1 in the G1 DNA damage checkpointEMBO J201029213723373220871591
   PubMed Web of Science ®Google Scholar
• ImbrianoCGnesuttaNMantovaniRThe NF-Y/p53 liaison: well beyond repressionBiochim Biophys Acta20111825213113922138487
   PubMed Web of Science ®Google Scholar
• ZhangWFengMZhengGChemoresistance to 5-fluorouracil induces epithelial-mesenchymal transition via up-regulation of Snail in MCF7 human breast cancer cellsBiochem Biophys Res Commun2012417267968522166209
   PubMed Web of Science ®Google Scholar
• WuFLiJJangCWangJXiongJThe role of Axl in drug resistance and epithelial-to-mesenchymal transition of non-small cell lung carcinomaInt J Clin Exp Pathol20147106653666125400744
   PubMed Web of Science ®Google Scholar
• BangSWKoMJKangSHuman TopBP1 localization to the mitotic centrosome mediates mitotic progressionExp Cell Res20113177994100421291884
   PubMed Web of Science ®Google Scholar
• JeonYKoELeeKYTopBP1 deficiency causes an early embryonic lethality and induces cellular senescence in primary cellsJ Biol Chem201128675414542221149450
   PubMed Web of Science ®Google Scholar
• ChoiSHYangHLeeSHKiJHNamDHYooHYTopBP1 and Claspin contribute to the radioresistance of lung cancer brain metastasesMol Cancer20141321125216549
   PubMed Web of Science ®Google Scholar
• ManfrediJJThe Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressorGenes Dev201024151580158920679392
   PubMed Web of Science ®Google Scholar
• MarteBCancer: super p53Nature2002420691327912447427
   PubMed Web of Science ®Google Scholar
• RileyTSontagEChenPLevineATranscriptional control of human p53-regulated genesNat Rev Mol Cell Biol20089540241218431400
   PubMed Web of Science ®Google Scholar
• Garcia-CaoIGarcia-CaoMMartin-CaballeroJ“Super p53” mice exhibit enhanced DNA damage response, are tumor resistant and age normallyEMBO J200221226225623512426394
   PubMed Web of Science ®Google Scholar
• VogelsteinBLaneDLevineAJSurfing the p53 networkNature2000408681030731011099028
   PubMed Web of Science ®Google Scholar
• SoussiTBeroudCAssessing TP53 status in human tumours to evaluate clinical outcomeNat Rev Cancer20011323324011902578
   PubMed Web of Science ®Google Scholar
• PapadogianniDSoulitzisNDelakasDSpandidosDAExpression of p53 family genes in urinary bladder cancer: correlation with disease aggressiveness and recurrenceTumour Biol20143532481248924213852
   PubMedGoogle Scholar
• ShetzerYSolomonHKoifmanGMolchadskyAHoreshSRotterVThe paradigm of mutant p53-expressing cancer stem cells and drug resistanceCarcinogenesis20143561196120824658181
   PubMed Web of Science ®Google Scholar
• KimCWLuJNGoSIp53 restoration can overcome cisplatin resistance through inhibition of Akt as well as induction of BaxInt J Oncol20134351495150223970333
   PubMed Web of Science ®Google Scholar